ELISpotおよびFluoroSpotアッセイ市場：製品、用途、エンドユーザー別-2024-2030年世界予測

ELISpotおよびFluoroSpotアッセイ市場規模は2023年に2億9,268万米ドルと推定され、2024年には3億1,361万米ドルに達すると予測され、CAGR 7.02%で2030年には4億7,074万米ドルに達すると予測されます。

ELISpotおよびFluoroSpotアッセイの世界市場

ELISpot（酵素結合免疫吸着スポット）アッセイは、サイトカイン分泌細胞数を評価することにより抗原特異的T細胞の量を測定する高感度かつ強力な免疫測定法です。FluoroSpotアッセイは、多機能性T細胞や単一サイトカイン産生細胞の数を可視化し、列挙することができます。FluoroSpotアッセイは、個々のサイトカインと共分泌サイトカインを区別するために、波長の重ならない蛍光ラベルを使用します。ELISPOTとfluoroSpotの両アッセイは、単一細胞レベルでの定量的情報とT細胞表現型の同定の両方が必要とされる臨床試験の免疫モニタリングに広く使用されています。世界中で慢性疾患の有病率が上昇し、生物医学研究が急増していることから、診断やモニタリングのための強固な免疫学的アッセイの導入が必要とされています。さらに、個別化医療への関心の高まりによる製薬・バイオテクノロジー分野への投資の増加も、これらのアッセイの応用範囲を広げています。しかし、アッセイ操作の複雑さや検査結果のばらつきが、アッセイの普及を妨げています。さらに、検査結果の解釈の難しさやELISpotおよびFluoroSpotアッセイによるデータ解析の複雑さが、ELISpotやFluoroSpotの利用をさらに複雑にしています。しかし、ヘルスケア業界は、アッセイの特異性と精度の向上を目指した研究開発イニシアチブと相まって、技術革新を継続的に推進しており、ELISpotとFluoroSpotアッセイを使用する際の技術的制約を克服することができます。がんやその他の疾患に対する免疫療法が重視されるようになり、ELISpotとFluoroSpotアッセイに対するニーズはさらに高まっています。

地域別の洞察

南北アメリカ地域におけるELISpotおよびFluoroSpotアッセイの継続的な成長は、ヘルスケアおよびバイオテクノロジー部門が確立されていること、研究開発に多額の投資が行われていること、主要な市場プレーヤーが存在することに起因しています。特に、強固なヘルスケア・インフラと医療支出の増加を背景に、米国がこの地域の成長を牽引しています。欧州もELISpotとFluoroSpotアッセイの主要地域のひとつであり、ドイツ、英国、フランス、イタリアなどの国々がこの技術の成長を牽引しています。欧州の成長の原動力となっているのは、高度なヘルスケアシステムと定評ある研究機関の存在です。さらに、学術機関と産業界との連携がアッセイ開発の革新を促進しています。欧州市場はまた、先進的なELISpotおよびFluoroSpotアッセイの開発を目指す規制当局の支援政策からも恩恵を受けています。APAC地域では、高度な免疫診断技術に関する認知度の向上、慢性疾患に対する意識の高まり、ヘルスケア成果の向上を目的とした政府の取り組みなどにより、ELISpotおよびFluoroSpotアッセイのニーズが拡大しています。さらに、この地域にはCRO（医薬品開発業務受託機関）が存在するため、アジア太平洋地域は両アッセイの成長にとって重要な地域となっています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはELISpotおよびFluoroSpotアッセイ市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、ELISpotおよびFluoroSpotアッセイ市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-ELISpotおよびFluoroSpotアッセイ市場の市場規模および予測は？

2-ELISpotおよびFluoroSpotアッセイ市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-ELISpotおよびFluoroSpotアッセイ市場における技術動向と規制の枠組みは？

4-ELISpotおよびFluoroSpotアッセイ市場における主要ベンダーの市場シェアは？

5-ELISpotおよびFluoroSpotアッセイ市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患や感染症の罹患率の増加
    • 免疫療法と個別化医療のニーズの高まり
    • 免疫モニタリング研究の増加により使用量が増加
  • 抑制要因
    • アッセイプロトコルの複雑さと変動性
  • 機会
    • ユーザーフレンドリーでハイスループットなアッセイシステムの開発の進歩
    • 獣医学用途におけるELISpotおよびFluoroSpotアッセイの高い可能性
  • 課題
    • eLISpotおよびFluoroSpotアッセイによる解釈とデータ分析の複雑さ
• 市場セグメンテーション分析
  • 製品：調査機関や研究所の間で包括的なアッセイキットに対する支持が高まっています
  • 応用：腫瘍学の調査、診断、治療を推進するための政府の取り組みを拡大する
  • エンドユーザー：調査および臨床実践におけるELISpotおよびFluoroSpotアッセイの関連使用により、前例のない精度と信頼性の高い結果が得られます。
• 市場動向分析
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み

第6章 ELISpotおよびFluoroSpotアッセイ市場：製品別

• アクセサリ
• アナライザー
• アッセイキット

第7章 ELISpotおよびFluoroSpotアッセイ市場：用途別

• 自己免疫疾患
• 感染症
• 腫瘍学
• 臓器移植
• ワクチン開発

第8章 ELISpotおよびFluoroSpotアッセイ市場：エンドユーザー別

• 学術調査機関
• 病院と臨床検査室

第9章 南北アメリカのELISpotおよびFluoroSpotアッセイ市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のELISpotおよびFluoroSpotアッセイ市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのELISpotおよびFluoroSpotアッセイ市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ主要企業別の分析
  • 新製品発売と機能強化
  • 投資、資金調達
  • 受賞・表彰・拡大

第13章 競争力のあるポートフォリオ

• 主要な企業プロファイル
  • Abcam PLC
  • Abnova Corporation
  • Agilent Technologies, Inc.
  • Anogen-Yes Biotech Laboratories Ltd
  • Autoimmun Diagnostika GmbH
  • Becton, Dickinson and Company
  • Bio-Techne Corporation
  • BIOSYS Scientific Devices GmbH
  • BOC Sciences
  • Broughton Life Sciences Limited
  • CellCarta Biosciences Inc.
  • Creative Proteomics
  • Elabscience
  • Full Moon BioSystems, Inc.
  • Jackson ImmunoResearch Inc.
  • Mabtech AB
  • Merck KGaA
  • Oxford Immunotec USA, Inc.
  • Oy Medix Biochemica Ab
  • ProImmune Ltd.
  • Quansys Biosciences Inc.
  • SBH Sciences
  • U-CyTech BV
  • ZenBio, Inc.
• 主要な製品ポートフォリオ

第14章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. ELISPOT & FLUOROSPOT ASSAY MARKET RESEARCH PROCESS
• FIGURE 2. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, 2023 VS 2030
• FIGURE 3. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. ELISPOT & FLUOROSPOT ASSAY MARKET DYNAMICS
• FIGURE 7. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 10. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 12. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. ELISPOT & FLUOROSPOT ASSAY MARKET, FPNV POSITIONING MATRIX, 2023
• FIGURE 22. ELISPOT & FLUOROSPOT ASSAY MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

• TABLE 1. ELISPOT & FLUOROSPOT ASSAY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 6. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ACESSORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 10. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ORGAN TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 16. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. CANADA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. CANADA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. CANADA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. CHINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. CHINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. CHINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. INDIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. INDIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. INDIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. ITALY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. ITALY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. ITALY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. POLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. POLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. POLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. QATAR ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. QATAR ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. QATAR ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. ELISPOT & FLUOROSPOT ASSAY MARKET, FPNV POSITIONING MATRIX, 2023
• TABLE 146. ELISPOT & FLUOROSPOT ASSAY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. ELISPOT & FLUOROSPOT ASSAY MARKET LICENSE & PRICING

[184 Pages Report] The ELISpot & FluoroSpot Assay Market size was estimated at USD 292.68 million in 2023 and expected to reach USD 313.61 million in 2024, at a CAGR 7.02% to reach USD 470.74 million by 2030.

Global ELISpot & FluoroSpot Assay Market

ELISpot (enzyme-linked immunosorbent spot) assays are sensitive and potent immunoassays that measure the quantity of antigen-specific T cells by evaluating the number of cytokine-secreting cells. FluoroSpot assays can visualize and enumerate the number of polyfunctional T cells and single-cytokine producers. FluoroSpot assay uses fluorescent labels with discrete, non-overlapping wavelengths to differentiate individual cytokines and co-secreted cytokines. Both ELISPOT and fluoroSpot assays are widely used in immuno-monitoring of clinical trials where both quantitative information and T cell phenotype identification at a single cell level are required. The rising increasing prevalence of chronic diseases across the world and a surge in biomedical research have necessitated the deployment of robust immunological assays for diagnosis and monitoring. Furthermore, the rise in investments in the pharmaceutical and biotechnology sectors, driven by a growing focus on personalized medicine, has expanded the application scope of these assays. However, the complexity of operating the assay and the chances of variability in test results impede the widespread adoption of the assays. Additionally, the difficulty of interpretation of test results and data analysis complexities with ELISpot & FluoroSpot assays further pose complications for utilization of ELISpot and FluoroSpot. However, the healthcare industry's continuous push toward innovation coupled with R&D initiatives aimed towards improving the specificity and accuracy of the assays can overcome the technical constraints of using ELISpot and FluoroSpot assay. A growing emphasis on immunotherapy treatments for cancer and other diseases further creates a significant need for ELISpot and FluoroSpot assays.

Regional Insights

The continued growth of ELISpot and FluoroSpot assays in the Americas region can be credited to its well-established healthcare and biotechnological sectors, significant investments in research and development, and the presence of major market players. Particularly, the United States, with a robust healthcare infrastructure and increased healthcare spending, is driving the growth in this region. Europe is another key region for the ELISpot and FluoroSpot assays, with countries such as Germany, the United Kingdom, France, and Italy leading the growth of the technology. The growth in Europe is driven by advanced healthcare systems and the presence of reputed research institutions. Moreover, collaborations between academic institutions and the industry foster innovation in assay development. The European market also benefits from supportive regulatory policies aimed towards the development of advanced ELISpot and FluoroSpot assays. In the APAC region, the need for ELISpot and FluoroSpot assays is expanding due to increased awareness regarding advanced immunodiagnostic techniques, increased awareness about chronic diseases, and government initiatives aimed at enhancing healthcare outcomes. Furthermore, the presence of contract research organizations (CROs) in this region positions the Asia Pacific as a prominent region for the growth of both assays.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the ELISpot & FluoroSpot Assay Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the ELISpot & FluoroSpot Assay Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the ELISpot & FluoroSpot Assay Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Abnova Corporation, Agilent Technologies, Inc., Anogen-Yes Biotech Laboratories Ltd, Autoimmun Diagnostika GmbH, Becton, Dickinson and Company, Bio-Techne Corporation, BIOSYS Scientific Devices GmbH, BOC Sciences, Broughton Life Sciences Limited, CellCarta Biosciences Inc., Creative Proteomics, Elabscience, Full Moon BioSystems, Inc., Jackson ImmunoResearch Inc., Mabtech AB, Merck KGaA, Oxford Immunotec USA, Inc., Oy Medix Biochemica Ab, ProImmune Ltd., Quansys Biosciences Inc., SBH Sciences, U-CyTech BV, and ZenBio, Inc..

Market Segmentation & Coverage

This research report categorizes the ELISpot & FluoroSpot Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Acessories
  • Analyzers
  • Assay Kits
• Application
  • Autoimmune Disorders
  • Infectious Diseases
  • Oncology
  • Organ Transplantation
  • Vaccine Development
• End-User
  • Academic Research Institutes
  • Hospitals & Clinical Laboratories
• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the ELISpot & FluoroSpot Assay Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the ELISpot & FluoroSpot Assay Market?

3. What are the technology trends and regulatory frameworks in the ELISpot & FluoroSpot Assay Market?

4. What is the market share of the leading vendors in the ELISpot & FluoroSpot Assay Market?

5. Which modes and strategic moves are suitable for entering the ELISpot & FluoroSpot Assay Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. ELISpot & FluoroSpot Assay Market, by Region

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of chronic and infectious diseases
    • 5.1.1.2. Rising need for immunotherapy and personalized medicines
    • 5.1.1.3. Growing usage owing to an increase in immune monitoring studies
  • 5.1.2. Restraints
    • 5.1.2.1. Complexity and variability of assay protocols
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in the development of user-friendly and high-throughput assay systems
    • 5.1.3.2. High potential of eLISpot & fluoroSpot assay in veterinary applications
  • 5.1.4. Challenges
    • 5.1.4.1. Interpretation and data analysis complexities with eLISpot & fluoroSpot assays
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Growing preference for comprehensive assay kits among research institutions and laboratories
  • 5.2.2. Application: Expanding government initiatives to propel oncology research, diagnosis, and therapy
  • 5.2.3. End-user: Pertaining use of ELISpot & FluoroSpot assays in research and clinical practices providing unprecedented accuracy and reliable results
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework

6. ELISpot & FluoroSpot Assay Market, by Product

• 6.1. Introduction
• 6.2. Acessories
• 6.3. Analyzers
• 6.4. Assay Kits

7. ELISpot & FluoroSpot Assay Market, by Application

• 7.1. Introduction
• 7.2. Autoimmune Disorders
• 7.3. Infectious Diseases
• 7.4. Oncology
• 7.5. Organ Transplantation
• 7.6. Vaccine Development

8. ELISpot & FluoroSpot Assay Market, by End-User

• 8.1. Introduction
• 8.2. Academic Research Institutes
• 8.3. Hospitals & Clinical Laboratories

9. Americas ELISpot & FluoroSpot Assay Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific ELISpot & FluoroSpot Assay Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa ELISpot & FluoroSpot Assay Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player
  • 12.3.1. New Product Launch & Enhancement
    • 12.3.1.1. Celerion Expands Its Service Offering to Include GLP/GCP Compliant Molecular and Cell Biology Testing
  • 12.3.2. Investment & Funding
    • 12.3.2.1. Singamaneni to develop advanced protein imaging method
  • 12.3.3. Award, Recognition, & Expansion
    • 12.3.3.1. PerkinElmer's Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection

13. Competitive Portfolio

• 13.1. Key Company Profiles
  • 13.1.1. Abcam PLC
  • 13.1.2. Abnova Corporation
  • 13.1.3. Agilent Technologies, Inc.
  • 13.1.4. Anogen-Yes Biotech Laboratories Ltd
  • 13.1.5. Autoimmun Diagnostika GmbH
  • 13.1.6. Becton, Dickinson and Company
  • 13.1.7. Bio-Techne Corporation
  • 13.1.8. BIOSYS Scientific Devices GmbH
  • 13.1.9. BOC Sciences
  • 13.1.10. Broughton Life Sciences Limited
  • 13.1.11. CellCarta Biosciences Inc.
  • 13.1.12. Creative Proteomics
  • 13.1.13. Elabscience
  • 13.1.14. Full Moon BioSystems, Inc.
  • 13.1.15. Jackson ImmunoResearch Inc.
  • 13.1.16. Mabtech AB
  • 13.1.17. Merck KGaA
  • 13.1.18. Oxford Immunotec USA, Inc.
  • 13.1.19. Oy Medix Biochemica Ab
  • 13.1.20. ProImmune Ltd.
  • 13.1.21. Quansys Biosciences Inc.
  • 13.1.22. SBH Sciences
  • 13.1.23. U-CyTech BV
  • 13.1.24. ZenBio, Inc.
• 13.2. Key Product Portfolio

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing